GeneNews Receives $608K Grant to Commercialize ColonSentry in Malaysia | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews today announced the approval of almost MYR1.9 million ($608,000) in a seed capital grant from the Malaysian Biotechnology Corporation to support the commercial launch of the ColonSentry colorectal cancer diagnostic test in Malaysia.

The test will be made available in Malaysia through GeneNews Diagnostics, a privately held Malaysian firm that will also work with GeneNews to introduce ColonSentry in the rest of Southeast Asia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.